Newsfeeds - Spark Newswire

1 minute read

Jazz Pharmaceuticals Announces Health Canada Approval Of Vyxeos

Today, 4:59 PM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced the Health Canada approval and availability of Vyxeos® (daunorubicin and cytarabine liposome for injection) for the treatment of adults with newly diagnosed

JAZZ

11 minute read

The Week In Cannabis: Justice Clarence Thomas, Mexico’s Decriminalization, Apple’s Policy Changes, Tilray And More

By Javier Hasse

Today, 4:59 PM

Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021.

AAPL

2 minute read

Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June

By Jelena Martinovic

Today, 4:59 PM

The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down 8.7%. After gaining 5.2% in 2020 when it ended at 44.39, the index is up 28.6% in 2021 and has gained 94.2% over the past year. The index dropped 38.3% from its 2021 closing high of 92.48 on February 10.

AGFY

16 minute read

A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)

By Benzinga Cannabis

Today, 4:59 PM

As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.

ABBV

1 minute read

Jazz Pharma’s Rylaze Scores FDA Approval For Blood Cancer

By Vandana Singh

Today, 4:59 PM

The FDA has approved Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic leukemia or…

JAZZ

2 minute read

Jazz Pharmaceuticals Announces FDA Orphan Drug Exclusivity For Xywav Oral Solution

By Bill Haddad

Today, 4:59 PM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has recognized seven years of Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium

JAZZ

5 minute read

New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End

By Rachael Green

Today, 4:59 PM

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only.

ARTL

6 minute read

14 Biotech Stocks To Watch Over The Next 6 Months

By Shanthi Rexaline

Today, 4:59 PM

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks.

AERI

1 minute read

FDA
News

Jazz Pharmaceuticals on June 22 Received FDA Orphan for their Treatment of Acute Lymphoblastic Leukemia

By Charles Gross

Today, 4:59 PM

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=773420

JAZZ

1 minute read

10 Biggest Price Target Changes For Tuesday

By Lisa Levin

Today, 4:59 PM

Goldman Sachs lowered Casey's General Stores, Inc. (NASDAQ: CASY) price target from $240 to $215. Casey's shares rose 2.5% to close at $201.89 on Monday.

APD